Skip to main content

Small, short-duration, dobutamine-induced perfusion defects are not associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic resonance stress imaging.

Publication ,  Journal Article
Jordan, JH; Haag, JC; Morgan, TM; Vasu, S; Stacey, B; Hamilton, C; Robinson, K; Kitzman, D; Thohan, V; Hundley, WG
Published in: J Comput Assist Tomogr
2014

OBJECTIVE: The objective of this study was to assess the frequency and prognostic utility of small, short-duration left ventricular myocardial perfusion defects during dobutamine cardiovascular magnetic resonance (DCMR) stress imaging. METHODS: We performed first-pass contrast-enhanced DCMR at peak stress in 331 consecutively recruited individuals (aged 68 ± 8 years, 50% men) at intermediate risk for a future cardiac event. Size, location, and persistence of low-signal intensity perfusion defects were recorded. Cardiac events were assessed by personnel blinded to imaging results for a median of 24 months after the DCMR. RESULTS: Among the 55 individuals (16.6%) who exhibited small (<25% myocardial thickness) and short-duration (<5 frames in persistence) perfusion defects, diabetes was more prevalent (P = 0.019) and no cardiac events were observed. Large, persistent perfusion defects were associated with coronary artery disease, prior myocardial infarction, and decreased left ventricular function (P < 0.001 for all) and increased 2-year risk for a cardiac event (hazard ratio, 10.3; P < 0.001; confidence interval, 3.3-33.0). CONCLUSIONS: In individuals with diabetes, hypertension, or coronary artery disease at intermediate risk for a future cardiac event, small, short-duration DCMR perfusion defects are not associated with increased 2-year risk for a subsequent cardiac event.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Comput Assist Tomogr

DOI

EISSN

1532-3145

Publication Date

2014

Volume

38

Issue

3

Start / End Page

427 / 433

Location

United States

Related Subject Headings

  • Vasodilator Agents
  • Survival Rate
  • Sensitivity and Specificity
  • Risk Factors
  • Reproducibility of Results
  • Prognosis
  • Prevalence
  • Nuclear Medicine & Medical Imaging
  • North Carolina
  • Myocardial Perfusion Imaging
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jordan, J. H., Haag, J. C., Morgan, T. M., Vasu, S., Stacey, B., Hamilton, C., … Hundley, W. G. (2014). Small, short-duration, dobutamine-induced perfusion defects are not associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic resonance stress imaging. J Comput Assist Tomogr, 38(3), 427–433. https://doi.org/10.1097/RCT.0000000000000046
Jordan, Jennifer H., Jason C. Haag, Timothy M. Morgan, Sujethra Vasu, Brandon Stacey, Craig Hamilton, Killian Robinson, Dalane Kitzman, Vinay Thohan, and William Gregory Hundley. “Small, short-duration, dobutamine-induced perfusion defects are not associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic resonance stress imaging.J Comput Assist Tomogr 38, no. 3 (2014): 427–33. https://doi.org/10.1097/RCT.0000000000000046.
Jordan, Jennifer H., et al. “Small, short-duration, dobutamine-induced perfusion defects are not associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic resonance stress imaging.J Comput Assist Tomogr, vol. 38, no. 3, 2014, pp. 427–33. Pubmed, doi:10.1097/RCT.0000000000000046.
Jordan JH, Haag JC, Morgan TM, Vasu S, Stacey B, Hamilton C, Robinson K, Kitzman D, Thohan V, Hundley WG. Small, short-duration, dobutamine-induced perfusion defects are not associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic resonance stress imaging. J Comput Assist Tomogr. 2014;38(3):427–433.

Published In

J Comput Assist Tomogr

DOI

EISSN

1532-3145

Publication Date

2014

Volume

38

Issue

3

Start / End Page

427 / 433

Location

United States

Related Subject Headings

  • Vasodilator Agents
  • Survival Rate
  • Sensitivity and Specificity
  • Risk Factors
  • Reproducibility of Results
  • Prognosis
  • Prevalence
  • Nuclear Medicine & Medical Imaging
  • North Carolina
  • Myocardial Perfusion Imaging